Date  |
|
| Oct 15, 2019 |
CEL-SCI Reports Recent Data Review by the Independent Data Monitoring Committee for Its Pivotal Phase 3 Head and Neck Cancer Study |
| Sep 3, 2019 |
CEL-SCI Corporation to Present at H.C. Wainwright 21st Annual Global Investment Conference |
| Aug 14, 2019 |
CEL-SCI Corporation Reports Third Quarter Fiscal 2019 Financial Results |
| Jul 23, 2019 |
CEL-SCI’s Scientific Review on Inflammatory Disease Therapies Published in Peer Reviewed Journal “International Immunopharmacology” |
| Jul 8, 2019 |
CEL-SCI Collaborators Presents Data for New Vaccine in the Treatment of Rheumatoid Arthritis at the International Conference on Immunity and Immunochemistry Meeting |
| Jun 10, 2019 |
CEL-SCI Corporation Set to Join Russell 3000® Index |
| Jun 3, 2019 |
CEL-SCI Corporation to Present at the 9th Annual LD Micro Invitational |
| May 14, 2019 |
CEL-SCI Corporation Reports Second Quarter Fiscal 2019 Financial Results |
| May 13, 2019 |
CEL-SCI Presents New Data for Its LEAPS Vaccine in the Treatment of Rheumatoid Arthritis at the American Association of Immunologists 103rd Annual Meeting |
| May 8, 2019 |
CEL-SCI Corporation Releases Letter to Shareholders |